🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Material Removal

Based on TikTok, the platform has removed problematic content and banned related hashtags and query recommendations. The organization said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also found communities with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or administering at home.

Within minutes of entering one group, a vendor shared contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Details and Pricing

Within these communities, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant medical dangers”.